menu
    • menu

    Company profile for Anokion SA

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Anokion SA (including our wholly-owned subsidiaries Anokion US, Inc. and Kanyos Bio, Inc.) is focused on improving the treatment and outcomes of autoimmune disease. Our proprietary antigen-specific immune tolerance technology is designed to be both more effective and specific than the current standard of care. Patients suffering from autoimmune diseases harbor immune cells that mistakenly recognize and attack the body’s o...
    Anokion SA (including our wholly-owned subsidiaries Anokion US, Inc. and Kanyos Bio, Inc.) is focused on improving the treatment and outcomes of autoimmune disease. Our proprietary antigen-specific immune tolerance technology is designed to be both more effective and specific than the current standard of care. Patients suffering from autoimmune diseases harbor immune cells that mistakenly recognize and attack the body’s own cells (self-proteins) as foreign entities. This can lead to tissue destruction, inflammation, and any number of serious complications. The cells that cause these erroneous attacks are known as autoreactive cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Anokion SASwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    EPFL Innovation Park-L Chemin de la Dent d’Oche 1A CH-1024 Ecublens
    Telephone
    Telephone
    +1 857.320.6607
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://anokion.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Anokion Completes Enrollment in ACeD-it, SynCeD Ph 2 Trials
    Anokion Completes Enrollment in ACeD-it, SynCeD Ph 2 Trials

    19 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241219771214/en

    BUSINESSWIRE
    19 Dec 2024
    Share Share
    CMI Media Group taps Anoki AI to fine-tune pharma ad targeting
    CMI Media Group taps Anoki AI to fine-tune pharma ad targeting

    17 Dec 2024

    // FIERCE PHARMA

    https://www.fiercepharma.com/marketing/cmi-media-group-taps-anoki-ai-fine-tune-pharma-ad-targeting-connected-tv

    FIERCE PHARMA
    17 Dec 2024
    Share Share
    Anokion Presents ANK-700 Data For Multiple Sclerosis
    Anokion Presents ANK-700 Data For Multiple Sclerosis

    18 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240917374019/en

    BUSINESSWIRE
    18 Sep 2024
    Share Share
    Anokion's KAN-101 Supports Celiac Disease-Modifying Potential
    Anokion's KAN-101 Supports Celiac Disease-Modifying Potential

    20 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240520638624/en

    BUSINESSWIRE
    20 May 2024
    Share Share
    Anokion to Participate in BofA Healthcare Trailblazers Conference
    Anokion to Participate in BofA Healthcare Trailblazers Conference

    19 Oct 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231019195440/en

    BUSINESSWIRE
    19 Oct 2023
    Share Share
    Anokion Announces Nature Biomedical Engineering Publication
    Anokion Announces Nature Biomedical Engineering Publication

    19 Sep 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230919542875/en

    BUSINESSWIRE
    19 Sep 2023
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search